PCIM&H appoints Dr Raman Mohan Singh as new Director

Ghaziabad: Dr Raman Mohan Singh has been appointed as the new Director of the Pharmacopoeia Commission for Indian Medicine and Homoeopathy (PCIM&H).

The office memorandum issued by PCIM&H on November 4, stated that Dr Singh had taken over the charge from Professor VK Prajapati, Director (I/c), PCIM&H, on November 1.

"In pursuance to Ministry of AYUSH, Dr Raman Mohan Singh has taken over the charge from Prof. (Vd.) P.K. Prajapati, Director, I/c, PCIM&H, Ghaziabad in the forenoon of 1st November, 2022 for the post of Director, Pharmacopoeia Commission for Indian Medicine and Homoeopathy (PCIM&H), Ghaziabad," stated the office memorandum.

Also read- Savvy Group Founder Jaxay Shah Appointed As QCI New Chairman

Dr Singh was earlier the director of the Central Drug Testing Laboratory and in 2016, he was given the charge of government analyst by the central government with immediate effect.

Apart from this, PCIM&H, in collaboration with the World Health Organization-South East Asia Region (WHO-SEARO) has taken a major stride to upgrading laboratory capacity for quality control of traditional herbal products in the South East Asia region. In this regard, a three-day training programme was inaugurated by Pramod Kumar Pathak, Special Secretary, Ministry of AYUSH, in presence of Dr Kim Sungchol, Regional Adviser, Traditional Medicine, WHO-SEARO; Dr Raman Mohan Singh, Director, PCIM&H and other dignitaries, on 1st November 2022.

A total of 23 participants from 9 countries (Bhutan, Indonesia, India, Sri Lanka, Thailand, Nepal, Maldives, Timor Leste, and Bangladesh) are participating in this training program. The objective of the training is to impart skills for laboratory-based techniques and methods to maintain the quality of Traditional/herbal products.

Speaking on the occasion, Shri Pramod Kumar Pathak, Special Secretary, Ministry of Ayush said, "As per the Research and Information System Centre for Developing Countries report, the industry is projected to reach US$ 23.3 billion in 2022. With the increasing market, the quality issues of herbal material is also becoming increasingly worrying due to adulteration. The uniformity in Lab-based Quality Control will be able to evaluate the quality of the herbals often altered by various physical, chemical, and geographical aspects."

Dr Kim Sungchol, Regional Advisor-Traditional Medicine at, WHO South-East Asia regional office, said, "WHO-SEARO has successfully organized regional workshops and training for other countries. One of the key recommendations that were made by member countries during these regional workshops was to ensure regulatory capacity and that is why we are organizing this first training session in collaboration with PCIM&H, Ministry of Ayush."

Also read- Bhushan Akshikar Appointed As GSK Pharma MD